Willie Muehlhausen

Digital Innovator, Managing Director/Co-Founder
Safira Clinical Research Ltd, Ireland
Willie started his business in 2018 after spending more than 20 years in the clinical research industry working for CROs and technology companies in Germany, UK, US and Ireland. He served as the inaugural Vice-Director of the C-Path ePRO Consortium shaping the initial work of the founding members and is an active member in DIME, DIA and ISPOR research groups. In recent years he initiated and directed research on multiple patient-facing technologies (i.e. ePRO / BYOD, Wearables, Patient Burden, Fraud Detection via Machine Learning) and co-authored more than 40 publications and two books on electronic Patient Reported Outcome. Willie successfully developed multiple product and service lines in the eCOA space including the first dedicated ePRO Management group within a global CRO. His work has been recognized by his industry peers by including him in the PharmaVoice100 in 2015 and the CenterWatch Top 20 Innovators in 2018.

Events/Masterclasses Willie Muehlhausen is currently speaking at

Pharma

Clinical Outcome Assessments
30. September - 1. October 2021
Online Live Stream | 13:30 – 18:00 CEST
This interactive course is recommended for those who have experience in clinical trials & patient engagement and wish to develop their skills on how PRO measurement is best implemented to advance patient care.

Are you interested in a custom-made event with this trainer?

Contact us to Request more information about your custom-made Corporate Learning program.

REQUEST MORE INFORMATION

Willie Muehlhausen
Digital Innovator, Managing Director/Co-Founder
Safira Clinical Research Ltd, Ireland
Willie started his business in 2018 after spending more than 20 years in the clinical research industry working for CROs and technology companies in Germany, UK, US and Ireland. He served as the inaugural Vice-Director of the C-Path ePRO Consortium shaping the initial work of the founding members and is an active member in DIME, DIA and ISPOR research groups. In recent years he initiated and directed research on multiple patient-facing technologies (i.e. ePRO / BYOD, Wearables, Patient Burden, Fraud Detection via Machine Learning) and co-authored more than 40 publications and two books on electronic Patient Reported Outcome. Willie successfully developed multiple product and service lines in the eCOA space including the first dedicated ePRO Management group within a global CRO. His work has been recognized by his industry peers by including him in the PharmaVoice100 in 2015 and the CenterWatch Top 20 Innovators in 2018.
Willie Muehlhausen
Description